Newmanbrain Receives Innovation Award and Strengthens Its Position in the Neurotechnology Sector
Newmanbrain receives the Technology-Based and Innovative Company Award at the “XIX edición de los Premios del Consejo Social de la Universidad Miguel Hernández (UMH)”
Newmanbrain’s Theia Receives European Union MDR Certification
Theia, Newmanbrain’s innovative brain health assessment device, has received European Union MDR certification, validating its safety, quality, and clinical performance.
NEWMANBRAIN Honored at the “XIX edición de los Premios del Consejo Social de la UMH”
NEWMANBRAIN has received the XIX UMH Social Council Award, recognizing its commitment to innovation, technology, and knowledge transfer. A milestone that reflects the dedication and talent of the entire team.
An Incredible Experience at MedTech World North America 2026
MedTech World North America was an incredible experience that reinforced our confidence in the future of our solution. Beyond the competition, the event allowed us to build valuable connections with industry leaders, investors, and innovators, confirming that this is only the beginning of our journey.
Newmanbrain Nominated for the 2026 MedTech World North America Awards
Newmanbrain has been nominated for the Best Patient Impact Award at the MedTech World North America Awards, recognizing its commitment to improving patient outcomes through innovation and teamwork.
Salud e innovación para el bienestar real
Pablo Belmonte, CEO of Newmanbrain, joined a roundtable at the Parque Científico de Alicante to discuss how health innovation is shaping real wellbeing.
Newmanbrain Presents the THEIA System at Longevity World Forum 2026
At Longevity World Forum 2026 in Madrid, Newmanbrain introduced THEIA, an innovative system designed for the early detection of Mild Cognitive Impairment. The event brought together global leaders in longevity and health technology, highlighting the growing importance of preventive cognitive care.
SOMMa Strengthens Knowledge Transfer at Science 4 Industry in Madrid
SOMMa highlights cutting-edge technologies from Severo Ochoa and María de Maeztu centers at Science 4 Industry, boosting knowledge transfer between research and industry.
Newmanbrain and NeurotechEU: a strategic alliance to promote neurotechnology in Europe
The collaboration between Newmanbrain and NeurotechEU advances neurotechnology in Europe by combining neuroscience research, artificial intelligence, and biomedical innovation to improve brain analysis and neurological research.
NewmanBrain Shines at the NeurotechEU 2025 Summit
The spin-off NewmanBrain, linked to the UMH Science Park, played a prominent role at the recent NeurotechEU 2025 Neuroinnovation Summit, held in Bodrum (Turkey).